Frontlight ResearchEarly access
Trial site
Institute for Cardiovascular Diseases Dedinje
- 6running trials
- 7closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease6 trials
- Heart failure3 trials
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- Stroke1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Institute for Cardiovascular Diseases Dedinje3 trials
- Boehringer Ingelheim2 trials
- Janssen Research & Development, LLC2 trials
- Population Health Research Institute2 trials
- Bio Refine Ltd.1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease2 recruiting
- Heart failure1 recruiting
Closed trials
Recruiting
Bio Refine for Functional Mitral Regurgitation - a Safety & Feasibility Study
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Completed
Completed
Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry
Site data: ClinicalTrials.govUpdated 17 Nov 2026